ClearPoint Neuro (CLPT) - Cuộc họp công bố kết quả kinh doanh Q3 2026: Doanh thu tăng 36%, Hướng tới các động lực tăng trưởng năm 2027
Báo cáo kết quả kinh doanh quý 3/2026 của ClearPoint Neuro: doanh thu tăng 36% lên 12,1 triệu USD, lượng tiền mặt đạt 46,2 triệu USD và ban lãnh đạo đã nêu rõ các động lực tăng trưởng chính trong năm 2027.
ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.